vs
Copart（CPRT）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Copart的季度营收约是Royalty Pharma plc的1.9倍（$1.2B vs $622.0M），Copart净利率更高（35.0% vs 34.4%，领先0.5%），Royalty Pharma plc同比增速更快（4.8% vs 0.7%），过去两年Copart的营收复合增速更高（6.4% vs 4.6%）
Copart是一家跨国在线车辆拍卖及再营销服务提供商，服务保险、租车、车队、金融公司等各类汽车经销商，业务覆盖美国、加拿大、英国、德国等11个国家。总部位于美国得克萨斯州达拉斯，拥有200多处实体网点，运营总面积超1万英亩的车辆存放场地。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CPRT vs RPRX — 直观对比
营收规模更大
CPRT
是对方的1.9倍
$622.0M
营收增速更快
RPRX
高出4.1%
0.7%
净利率更高
CPRT
高出0.5%
34.4%
两年增速更快
CPRT
近两年复合增速
4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $622.0M |
| 净利润 | $403.7M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 37.3% | 62.4% |
| 净利率 | 35.0% | 34.4% |
| 营收同比 | 0.7% | 4.8% |
| 净利润同比 | 11.5% | 2.9% |
| 每股收益（稀释后） | $0.41 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPRTRPRX
| Q4 25 | $1.2B | $622.0M | ||
| Q3 25 | $1.1B | $609.3M | ||
| Q2 25 | $1.2B | $578.7M | ||
| Q1 25 | $1.2B | $568.2M | ||
| Q4 24 | $1.1B | $593.6M | ||
| Q3 24 | $1.1B | $564.7M | ||
| Q2 24 | $1.1B | $537.3M | ||
| Q1 24 | $1.0B | $568.0M |
净利润CPRTRPRX
| Q4 25 | $403.7M | $214.2M | ||
| Q3 25 | $396.4M | $288.2M | ||
| Q2 25 | $406.6M | $30.2M | ||
| Q1 25 | $387.4M | $238.3M | ||
| Q4 24 | $362.1M | $208.2M | ||
| Q3 24 | $322.6M | $544.0M | ||
| Q2 24 | $382.3M | $102.0M | ||
| Q1 24 | $325.6M | $4.8M |
营业利润率CPRTRPRX
| Q4 25 | 37.3% | 62.4% | ||
| Q3 25 | 36.7% | 70.1% | ||
| Q2 25 | 37.3% | 36.3% | ||
| Q1 25 | 36.6% | 94.0% | ||
| Q4 24 | 35.4% | 60.9% | ||
| Q3 24 | 33.6% | — | ||
| Q2 24 | 38.8% | 50.2% | ||
| Q1 24 | 37.2% | -13.0% |
净利率CPRTRPRX
| Q4 25 | 35.0% | 34.4% | ||
| Q3 25 | 35.2% | 47.3% | ||
| Q2 25 | 33.6% | 5.2% | ||
| Q1 25 | 33.3% | 41.9% | ||
| Q4 24 | 31.6% | 35.1% | ||
| Q3 24 | 30.2% | 96.3% | ||
| Q2 24 | 33.9% | 19.0% | ||
| Q1 24 | 31.9% | 0.8% |
每股收益（稀释后）CPRTRPRX
| Q4 25 | $0.41 | $0.49 | ||
| Q3 25 | $0.40 | $0.67 | ||
| Q2 25 | $0.42 | $0.07 | ||
| Q1 25 | $0.40 | $0.55 | ||
| Q4 24 | $0.37 | $0.46 | ||
| Q3 24 | $0.34 | $1.21 | ||
| Q2 24 | $0.39 | $0.23 | ||
| Q1 24 | $0.33 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $9.6B | $9.7B |
| 总资产 | $10.6B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CPRTRPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $843.0M |
总债务CPRTRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | $0 | $7.6B | ||
| Q2 24 | $427.0K | $7.6B | ||
| Q1 24 | $453.0K | $6.1B |
股东权益CPRTRPRX
| Q4 25 | $9.6B | $9.7B | ||
| Q3 25 | $9.2B | $9.6B | ||
| Q2 25 | $8.8B | $9.5B | ||
| Q1 25 | $8.3B | $9.8B | ||
| Q4 24 | $7.9B | $10.3B | ||
| Q3 24 | $7.5B | $10.3B | ||
| Q2 24 | $7.2B | $9.8B | ||
| Q1 24 | $6.8B | $9.9B |
总资产CPRTRPRX
| Q4 25 | $10.6B | $19.6B | ||
| Q3 25 | $10.1B | $19.3B | ||
| Q2 25 | $9.7B | $18.3B | ||
| Q1 25 | $9.2B | $17.6B | ||
| Q4 24 | $8.9B | $18.2B | ||
| Q3 24 | $8.4B | $18.0B | ||
| Q2 24 | $8.0B | $17.7B | ||
| Q1 24 | $7.6B | $16.1B |
负债/权益比CPRTRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | 0.00× | 0.74× | ||
| Q2 24 | 0.00× | 0.78× | ||
| Q1 24 | 0.00× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $535.3M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $427.2M | — |
| 自由现金流率自由现金流/营收 | 37.0% | — |
| 资本支出强度资本支出/营收 | 9.4% | — |
| 现金转化率经营现金流/净利润 | 1.33× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $1.4B | — |
8季度趋势，按日历期对齐
经营现金流CPRTRPRX
| Q4 25 | $535.3M | $827.1M | ||
| Q3 25 | $438.5M | $702.6M | ||
| Q2 25 | $700.9M | $364.0M | ||
| Q1 25 | $178.1M | $596.1M | ||
| Q4 24 | $482.3M | $742.5M | ||
| Q3 24 | $439.2M | $703.6M | ||
| Q2 24 | $496.3M | $658.2M | ||
| Q1 24 | $161.8M | $664.6M |
自由现金流CPRTRPRX
| Q4 25 | $427.2M | — | ||
| Q3 25 | $350.8M | — | ||
| Q2 25 | $572.9M | — | ||
| Q1 25 | $61.5M | — | ||
| Q4 24 | $245.5M | — | ||
| Q3 24 | $301.3M | — | ||
| Q2 24 | $408.5M | — | ||
| Q1 24 | $38.8M | — |
自由现金流率CPRTRPRX
| Q4 25 | 37.0% | — | ||
| Q3 25 | 31.2% | — | ||
| Q2 25 | 47.3% | — | ||
| Q1 25 | 5.3% | — | ||
| Q4 24 | 21.4% | — | ||
| Q3 24 | 28.2% | — | ||
| Q2 24 | 36.2% | — | ||
| Q1 24 | 3.8% | — |
资本支出强度CPRTRPRX
| Q4 25 | 9.4% | — | ||
| Q3 25 | 7.8% | — | ||
| Q2 25 | 10.6% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | 20.6% | — | ||
| Q3 24 | 12.9% | — | ||
| Q2 24 | 7.8% | — | ||
| Q1 24 | 12.1% | — |
现金转化率CPRTRPRX
| Q4 25 | 1.33× | 3.86× | ||
| Q3 25 | 1.11× | 2.44× | ||
| Q2 25 | 1.72× | 12.06× | ||
| Q1 25 | 0.46× | 2.50× | ||
| Q4 24 | 1.33× | 3.57× | ||
| Q3 24 | 1.36× | 1.29× | ||
| Q2 24 | 1.30× | 6.45× | ||
| Q1 24 | 0.50× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPRT
| Services | $952.1M | 82% |
| Other | $203.0M | 18% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
